SCHEMBL5504642

SCHEMBL5504642

CCOc1ccccc1C(=O)Nc1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.83
KMT2A Q03164 3/20 0.83
RAB9A P51151 3/20 0.79
KCNK3 O14649 3/20 0.74
KCNK9 Q9NPC2 3/20 0.74
SGMS2 Q8NHU3 1/20 0.70
RXFP1 Q9HBX9 2/20 0.69
MAPT P10636 4/20 0.68
MAPK1 P28482 2/20 0.68
NPC1 O15118 1/20 0.68
TP53 P04637 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
HSD17B10 Q99714 1/20 0.67
HCRTR1 O43613 2/20 0.67
GAA P10253 1/20 0.67
ALDH1A1 P00352 3/20 0.66
ATM Q13315 1/20 0.66
NPSR1 Q6W5P4 1/20 0.66
GPR55 Q9Y2T6 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428095 0.89 MEN1 (0.77) MEN1KMT2ARAB9AKCNK3KCNK9
SCHEMBL4432149 0.89 RAB9A (0.84) MEN1KMT2ARAB9AKCNK3KCNK9
SCHEMBL5948558 0.88 MEN1 (0.71) MEN1KMT2ARAB9AKCNK3KCNK9
SCHEMBL15323117 0.87 MEN1 (0.69) MEN1KMT2ARAB9AKCNK3KCNK9
SCHEMBL4433023 0.86 KCNK3 (0.84) MEN1KMT2ARAB9AKCNK3KCNK9
SCHEMBL6778380 0.84 SGMS2 (0.76) KCNK3KCNK9SGMS2RXFP1MAPK1
SCHEMBL7105901 0.84 SGMS2 (0.70) MEN1KMT2ARAB9ASGMS2MAPT
SCHEMBL328592 0.83 GAA (0.74) MEN1KMT2ARAB9ARXFP1MAPT
SCHEMBL5657294 0.83 MEN1 (0.67) MEN1KMT2ARAB9AKCNK3KCNK9
SCHEMBL2116016 0.83 RXFP1 (0.64) MEN1KMT2ARAB9AKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814866-A2 GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS Wyeth a Corporation of the State of Delaware (US) 2007-08-08 EP claimed
WO-2006058012-A2 GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS WYETH (US) 2006-06-01 WO claimed
EP-3634372-A1 COATED PARTICLES AND THEIR USES Johnson & Johnson Consumer Inc. (US) 2020-04-15 EP disclosed
EP-3541360-A1 METHOD OF PROVIDING ORAL CARE BENEFITS Fertin Pharma A/S (DK) 2019-09-25 EP disclosed
WO-2018213418-A1 COATED PARTICLES AND THEIR USES JOHNSON & JOHNSON CONSUMER INC. (US) 2018-11-22 WO disclosed
WO-2018093501-A1 METHOD OF PROVIDING ORAL CARE BENEFITS FERTIN PHARMA A/S (DK) 2018-05-24 WO disclosed
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed
WO-1994026244-A1 ORAL CARE COMPOSITIONS CONTAINING ZINC OXIDE PARTICLES AND SODIUM BICARBONATE CHURCH & DWIGHT CO., INC. (US) 1994-11-24 WO disclosed